Disc Medicine, Inc. Investment Income, Interest
Disc Medicine, Inc. (IRON) reported Investment Income, Interest of $5.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2021-11-15
- Disc Medicine, Inc. investment income, interest for the quarter ending 2021-09-30 was $5.00K, a 400.00% increase year-over-year.
- Disc Medicine, Inc. investment income, interest for the quarter ending 2021-06-30 was $5.00K.
- Disc Medicine, Inc. investment income, interest for the quarter ending 2021-03-31 was $1.00K, a 97.22% decline year-over-year.
- Disc Medicine, Inc. investment income, interest for the quarter ending 2020-12-31 was $3.04K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2021-09-30 | $5.00K 10-Q · filed 2021-11-15 | $10.00K derived: sum of 2 quarters · filed 2021-11-15 | $11.00K 10-Q · filed 2021-11-15 | $14.04K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | $5.00K 10-Q · filed 2021-08-12 | $6.00K 10-Q · filed 2021-08-12 | $9.04K derived: sum of 3 quarters · filed 2021-08-12 | $10.53K derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | $1.00K 10-Q · filed 2021-05-13 | $4.04K derived: sum of 2 quarters · filed 2021-05-13 | $5.53K derived: sum of 3 quarters · filed 2021-05-13 | $5.53K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-12-31 | $3.04K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-29 | $4.53K 10-K · filed 2021-03-29 | $4.53K derived: sum of 3 quarters · filed 2021-08-12 | $40.53K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-15 | $1.49K derived: sum of 2 quarters · filed 2021-08-12 | $37.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $36.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $36.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |